long intergenic non-protein coding RNA 2175Genealiases: []
Q-omics provides the consensus-scored LINC02175 profile across patient tissues and cancer cell-line models. LINC02175 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, LINC02175 is differentially expressed in 12, with the highest sampling consensus in THCA. Additionally, LINC02175 RNA expression shows 19,689 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight BLCA, THCA, and UVM as cancer lineages where LINC02175 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02175 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02175 survival associations across molecular data types. LINC02175 RNA expression shows survival associations in the most cancer types (24). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02175 RNA expression–survival associations across cancer types. High LINC02175 expression shows unfavorable associations in BLCA, but favorable associations in LAML, READ, KIRC, SKCM and BRCA. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for LINC02175 RNA expression.
This table summarizes LINC02175 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02175. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02175 shows lower tumor expression in THCA, KICH, UCEC, BRCA and KIRC and higher tumor expression in LIHC. The THCA box plot shows higher LINC02175 RNA expression in normal versus tumor tissue (log2 FC = −0.572, t-test p < 0.001).
This table shows molecular features associated with LINC02175 in patient tissues and cancer cell lines. In patient samples, LINC02175 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
